Applied Therapeutics Forum: Community User: Reevo90
Applied Therapeutics (Nasdaq: APLT) agreed to be acquired by Cycle Group Holdings for $0.088 per share cash plus one non-transferrable contingent value right (CVR). The CVR can pay up to $0.10 for FDA approval in a galactosemia indication, $0.10 for FDA approval in CMT-SORD, and $0.20 upon first worldwide net sales ≥ $200M in any four-quarter period; CVR holders also share in a capped Closing Cash Payment tied to Applied cash above $500,000 (capped at $1.5M). The tender offer is expected to close in Q1 2026; the merger has no financing condition. Applied received an unsecured promissory note enabling up to $8.5M in loans to fund working capital.
|
|
Thema | ||
|---|---|---|---|
| 1 | Dynamite Blockchain | +52,00 % | |
| 2 | Trading- und Aktien-Chat | ||
| 3 | Metaplanet | +15,28 % | |
| 4 | ATOS Hauptdiskussion | -0,14 % | |
| 5 | Hydrogenpro Hauptdiskussion | -10,68 % | |
| 6 | Antimony Resources Corp. | +0,68 % | |
| 7 | BioXcel Therapeutics Inc Registered Shs Hauptdiskussion | +3,34 % | |
| 8 | VONOVIA Hauptdiskussion | ±0,00 % | |
| 9 | MICROSTRATEGY Hauptdiskussion | +9,05 % | |
| 10 | Freunde der Telekom | +0,40 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Dynamite Blockchain | +52,00 % | |
| 2 | Metaplanet | +14,60 % | |
| 3 | ATOS Hauptdiskussion | -0,14 % | |
| 4 | Hydrogenpro Hauptdiskussion | -10,68 % | |
| 5 | Antimony Resources Corp. | +0,68 % | |
| 6 | BioXcel Therapeutics Inc Registered Shs Hauptdiskussion | +3,34 % | |
| 7 | VONOVIA Hauptdiskussion | ±0,00 % | |
| 8 | MICROSTRATEGY Hauptdiskussion | +9,00 % | |
| 9 | Freunde der Telekom | +0,40 % | |
| 10 | Gamestop💎🙌 | +0,52 % | Alle Diskussionen |